BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1823857)

  • 1. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
    Bestagno M
    J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid.
    Schvartz C; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):332-3. PubMed ID: 1823850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [131I]metaiodobenzylguanidine therapy in medullary thyroid cancer: Guy's Hospital experience.
    Clarke SE
    J Nucl Biol Med (1991); 1991; 35(4):323-6. PubMed ID: 1823848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of [131I]metaiodobenzylguanidine in the treatment of medullary thyroid carcinoma: results in five cases.
    Troncone L; Rufini V; Maussier ML; Valenza V; Daidone MS; Luzi S; De Santis M
    J Nucl Biol Med (1991); 1991; 35(4):327-31. PubMed ID: 1823849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of [131I]metaiodobenzylguanidine therapy in medullary thyroid carcinoma.
    Hoefnagel CA; Delprat CC; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):334-6. PubMed ID: 1823851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid.
    Bestagno M; Pizzocaro C; Pagliaini R; Rossini PL; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):343-5. PubMed ID: 1823854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [131I]metaiodobenzylguanidine therapy in carcinoid tumors.
    Castellani MR; Di Bartolomeo M; Maffioli L; Zilembo N; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):349-51. PubMed ID: 1823855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Session on the role of [131I]metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report.
    Ackery DM; Troncone L
    J Nucl Biol Med (1991); 1991; 35(4):318-20. PubMed ID: 1823846
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview on the management of carcinoid tumors.
    Napolitano G; Bucci I; Lio S; Giuliani C; Minnucci A; Monaco F
    J Nucl Biol Med (1991); 1991; 35(4):337-40. PubMed ID: 1823852
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid tumors.
    Colombo L; Vignati A; Lomuscio G; Dottorini ME
    J Nucl Biol Med (1991); 1991; 35(4):352-4. PubMed ID: 1823856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of [131I]metaiodobenzylguanidine therapy in carcinoids.
    Hoefnagel CA; Taal BG; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):346-8. PubMed ID: 1726678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Session on the treatment of neuroblastoma with radioiodinated metaiodobenzylguanidine. Chairmen's report.
    Mastrangelo R; Voûte PA
    J Nucl Biol Med (1991); 1991; 35(4):260-2. PubMed ID: 1823831
    [No Abstract]   [Full Text] [Related]  

  • 13. Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report.
    Sisson JC; De Bernardi B
    J Nucl Biol Med (1991); 1991; 35(4):199-201. PubMed ID: 1823818
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
    Fischer M
    J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medullary carcinoma of the thyroid gland].
    Zarrilli L; Marzano LA; Porcelli A; Zarrilli S; D'Ajello M
    Chir Ital; 1994; 46(4):33-6. PubMed ID: 7882440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
    Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
    J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I]metaiodobenzylguanidine therapy in paraganglioma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Crippa F; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):315-7. PubMed ID: 1823845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.